文献

J-GLOBAL ID：201902218907354040   整理番号：19A1171157

転移性HER2陽性胃癌におけるドセタキセル,シスプラチン,及び5フルオロウラシル変法とトラスツズマブの第二相試験

Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer

著者 (29件)： Mondaca Sebastian (Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Margolis Matthew (Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Sanchez-Vega Francisco (Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Sanchez-Vega Francisco (Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Jonsson Philip (Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Jonsson Philip (Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Riches Jamie C. (Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Ku Geoffrey Y. (Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Hechtman Jaclyn F. (Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Tuvy Yaelle (Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Berger Michael F. (Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Berger Michael F. (Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Berger Michael F. (Physiology, Biophysics and Systems Biology Program, Weill Cornell Medical College, New York, NY, USA) ,  Shah Manish A. (Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Kelsen David P. (Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Ilson David H. (Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Yu Kenneth (Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Goldberg Zoe (Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Epstein Andrew S. (Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Desai Avni (Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Chung Vincent (Department of Medical Oncology and Therapeutics Research, City of Hope Cancer Center, Duarte, CA, USA) ,  Chou Joanne F. (Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Capanu Marinela (Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Solit David B. (Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Solit David B. (Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Solit David B. (Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Schultz Nikolaus (Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Schultz Nikolaus (Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA) ,  Janjigian Yelena Y. (Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA)
資料名： Gastric Cancer (Web)  (Gastric Cancer (Web))
巻： 22  号： 2  ページ： 355-362  発行年： 2019年 
JST資料番号： U0618A  ISSN： 1436-3291  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： ドイツ (DEU)  言語： 英語 (EN)

抄録/ポイント： 背景:トラスツズマブとシスプラチン及びフルオロピリミジンは転...

シソーラス用語： ヒト ,...
準シソーラス用語： HER2 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A1171157&from=J-GLOBAL&jstjournalNo=U0618A") }}

著者キーワード (4件)： 胃癌 ,  HER2 ,  トラスツズマブ ,  ドセタキセル

分類 (3件)： 消化器の腫よう  (GH04000D) ,  腫ようの薬物療法  (GE03032C) ,  抗腫よう薬の臨床への応用  (GW16020L)

物質索引 (2件)： 5-フルオロウラシル ,  ドセタキセル

タイトルに関連する用語 (7件)： 転移性 ,  HER2陽性胃癌 ,  ドセタキセル ,  シスプラチン ,  フルオロウラシル ,  トラスツズマブ ,  第二相試験